Global Fetal Bovine Serum Market Size Projected to Reach $1.31 Billion During the Forecast Period
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Does The Market Size Of The Fetal Bovine Serum Industry Compare Between 2025 And 2029?
The fetal bovine serum market size has shown consistent expansion in recent years. This market is expected to increase from $1.02 billion in 2024 to $1.06 billion in 2025, at a compound annual growth rate (CAGR) of 4.6%. The historical growth of this market stemmed from the expanding biopharmaceutical industry, the rising prevalence of cell-based therapies, and the necessity for quality and consistency.
The fetal bovine serum market is projected to experience substantial expansion over the next few years, with its size expected to reach $1.31 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.4%. This growth during the forecast period is primarily attributed to the rising adoption of cell therapies, the emergence of advanced therapeutics, an increased focus on animal-free alternatives, and strategic supplier-customer relationships. Key trends anticipated in this period include an emphasis on quality and traceability, strengthened global collaborations and partnerships, strategic mergers and acquisitions, the development of customized fetal bovine serum products, and adherence to regulatory compliance and ethical sourcing.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4109&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Fetal Bovine Serum Industry?
The burgeoning demand for biopharmaceuticals is anticipated to propel the expansion of the fetal bovine serum market throughout the forecast period. Biopharmaceuticals are medical products sourced from biological origins such as animals, humans, and microorganisms, developed through biotechnological processes. Fetal bovine serum (FBS) stands as the predominant alternative employed in animal cell culture media. Its essential nature leads pharmaceutical enterprises, diagnostic laboratories, and researchers to heavily rely on FBS for a substantial portion of their cell culture requirements within biologics research. Illustratively, in 2022, ProClinical Limited, a UK-based lifesciences service and consulting company, recorded sales of US$36.15mn from its pharmaceuticals and vaccines segments, representing an 11% increase year-over-year. This upward trend in biopharmaceutical demand thus acts as a key driver for the fetal bovine serum market’s growth.
What Are The Different Segment Classifications Within The Fetal Bovine Serum Market?
The fetal bovine serum market covered in this report is segmented –
1) By Product: Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Other Products
2) By Application: Drug Discovery, Cell Culture Media, In Vitro Fertilization, Human And Animal Vaccine Production, Diagnostics, Other Applications
3) By End-User: Research And Academic Institutes, Biotechnology And Pharmaceutical Industry, Other End-Users
Subsegments:
1) By Charcoal Stripped: Standard Charcoal Stripped FBS, Heat-Inactivated Charcoal Stripped FBS
2) By Chromatographic: Ion Exchange Chromatography Purified FBS, Affinity Chromatography Purified FBS
3) By Dialyzed Fetal Bovine Serum: Standard Dialyzed FBS, Heat-Inactivated Dialyzed FBS
4) By Exosome Depleted: Standard Exosome Depleted FBS, Heat-Inactivated Exosome Depleted FBS
5) By Stem Cell: Stem Cell Grade FBS, Knockout Serum Replacement
6) By Other Products: Serum from Specific Animal Breeds, Custom-Processed FBS
What Are The Major Trends Driving The Growth Of The Fetal Bovine Serum Market?
A significant trend emerging in the fetal bovine serum market involves the growing number of collaborations between businesses and research organizations. Leading companies are engaging in these partnerships to enhance their production capacities, broaden their market presence, and innovate new offerings. A notable example is the partnership between US-based GE Healthcare and New Zealand-based Oritain. They collaborated to create an independent testing method to verify the country of origin for fetal bovine serum (FBS). This development is beneficial for biomanufacturing entities, given that FBS sourced from various countries presents differing levels of risk concerning virus contamination.
Which Major Industry Participants Are Leading The Fetal Bovine Serum Market Growth?
Major companies operating in the fetal bovine serum market include Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Cytiva, VWR International, Sartorius AG, Bio-Techne Corporation, Atlas Biologicals Inc., R&D Systems Inc., Atlanta Biologicals Inc., Cyagen Biosciences, GenClone Inc., Gemini Bio-Products, Access Biologicals LLC, Nucleus Biologics, ZenBio Inc., Biowest, Bovogen Biologicals Pty Ltd., TCS Biosciences Ltd., J R Scientific Inc., Rocky Mountain Biologicals Inc., Tissue Culture Biologicals, Moregate Biotech, Cell Applications Inc., Altogen Biosystems, Axil Scientific Pte Ltd., Animal Technologies Inc., PAN- Biotech, PAA Laboratories GmbH, Peak Serum Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/fetal-bovine-serum-global-market-report
Which Region Is Expected To Witness The Fastest Growth In The Fetal Bovine Serum Market?
North America was the largest region in the fetal bovine serum market in 2024. Asia-Pacific recorded the fastest growth during the forecast period. The regions covered in the fetal bovine serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Fetal Bovine Serum Market Report:
https://www.thebusinessresearchcompany.com/customise?id=4109&type=smp
Browse Through More Reports Similar to the Global Fetal Bovine Serum Market 2025, By The Business Research Company
Dialysis Devices And Equipment Global Market Report 2025
Fetal And Neonatal Monitoring Devices Global Market Report 2025
Patient Monitoring Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/patient-monitoring-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
